| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adjunctive Eslicarbazepine Acetate in Pediatric Patients with Focal Epilepsy: A Systematic Review and Meta-Analysis
|
Lattanzi, Simona
|
|
2018
|
32 |
3 |
p. 189-196
|
article
|
| 2 |
A Double-Blind, Placebo-Controlled, Phase II Study to Determine the Efficacy, Safety, Tolerability and Pharmacokinetics of a Controlled Release (CR) Formulation of Mazindol in Adults with DSM-5 Attention-Deficit/Hyperactivity Disorder (ADHD)
|
Wigal, Tim L.
|
|
2018
|
32 |
3 |
p. 289-301
|
article
|
| 3 |
Author Correction to: l-Acetyl-carnitine in Patients with Carpal Tunnel Syndrome: Effects on Nerve Protection, Hand Function and Pain
|
Cruccu, Giorgio
|
|
2018
|
32 |
3 |
p. 303
|
article
|
| 4 |
Convergent Mechanisms Underlying Rapid Antidepressant Action
|
Zanos, Panos
|
|
2018
|
32 |
3 |
p. 197-227
|
article
|
| 5 |
Efficacy and Safety of the Newer Multiple Sclerosis Drugs Approved Since 2010
|
Faissner, Simon
|
|
|
32 |
3 |
p. 269-287
|
article
|
| 6 |
Efficacy and Safety of the Newer Multiple Sclerosis Drugs Approved Since 2010
|
Faissner, Simon
|
|
2018
|
32 |
3 |
p. 269-287
|
article
|
| 7 |
Gadolinium-Based Contrast Agent-Related Toxicities
|
Pasquini, Luca
|
|
2018
|
32 |
3 |
p. 229-240
|
article
|
| 8 |
Long-Acting Injectable Second-Generation Antipsychotics: An Update and Comparison Between Agents
|
Jann, Michael W.
|
|
2018
|
32 |
3 |
p. 241-257
|
article
|
| 9 |
Newer Antiepileptic Drugs for Status Epilepticus in Adults: What’s the Evidence?
|
Beuchat, Isabelle
|
|
2018
|
32 |
3 |
p. 259-267
|
article
|
Journal description